Clinical Trial Update: A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) [Phase 2]

View source ↗

Summary

Phase 2 study of Rosnilimab in moderate-to-severe rheumatoid arthritis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rosnilimab (Rosnilimab)

Snippet

Sponsor: AnaptysBio, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING